Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Drugging cancer genomes

Subjects

A recent landmark analysis compared genome-wide mutations and associated 'omics' features for 3,281 tumours across 12 human cancer types. There is a clear need for objective target assessment and prioritization by the drug discovery community to make the best use of such vast amounts of data.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Kandoth, C. et al. Mutational landscape and significance across 12 major cancer types. Nature 502, 333–339 (2013).

    CAS  Article  Google Scholar 

  2. 2

    Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546–1558 (2013).

    CAS  Article  Google Scholar 

  3. 3

    Futreal, P. A. et al. A census of human cancer genes. Nature Rev. Cancer 4, 177–183 (2004).

    CAS  Article  Google Scholar 

  4. 4

    Patel, M. N. et al. Objective assessment of cancer genes for drug discovery. Nature Rev. Drug Discov. 12, 35–50 (2013).

    CAS  Article  Google Scholar 

  5. 5

    Halling-Brown, M. D. et al. canSAR: an integrated cancer public translational research and drug discovery resource. Nucleic Acids Res. 40, D947–D956 (2012).

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Paul Workman or Bissan Al-Lazikani.

Ethics declarations

Competing interests

The authors work at The Institute of Cancer Research, London, UK, which has a commercial interest in the discovery and development of anticancer drugs.

Supplementary information

Supplementary information S1 (box)

Objective analysis of cancer genes (PDF 2031 kb)

Related links

Related links

FURTHER INFORMATION

The Cancer Genome Atlas

International Cancer Genome Consortium

Focus on TCGA Pan-Cancer Analysis

canSAR knowledgebase

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Workman, P., Al-Lazikani, B. Drugging cancer genomes. Nat Rev Drug Discov 12, 889–890 (2013). https://doi.org/10.1038/nrd4184

Download citation

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing